Stocks
ImmunoGen, Inc.IMGN
NASDAQHealthcareBiotechnology$31.23+0.02%
A biotechnology company focused on developing antibody-drug conjugate (ADC) therapies for cancer. Its lead products and pipeline target ovarian and other solid tumors by combining tumor‑targeting antibodies with potent cell‑killing agents. Investors track the firm for clinical trial results, regulat...
Market Cap: $8.7B52W Range: $3.61 – $31.25
Congressional Interest in ImmunoGen, Inc. (IMGN)
1 member of Congress has disclosed 2 trades in ImmunoGen, Inc. (IMGN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading IMGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-01-09 | Thomas MacArthur | buy | $1K – $15K |
| 2016-12-08 | Thomas MacArthur | sell | $1K – $15K |